AU Patent

AU2002303425A1 — Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent

Assigned to Epigenesis Pharmaceuticals Inc · Expires 2002-11-05 · 24y expired

What this patent protects

Patent listed against azelastine-hydrochloride.

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2002303425A1
Jurisdiction: AU
Classification: —
Expires: 2002-11-05
Drug substance claim: No
Drug product claim: No
Assignee: Epigenesis Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.